Log in

Intuitive Surgical Stock Price, Forecast & Analysis (NASDAQ:ISRG)

+15.10 (+2.72 %)
(As of 11/16/2019 08:00 AM ET)
Today's Range
Now: $569.54
50-Day Range
MA: $542.22
52-Week Range
Now: $569.54
Volume837,500 shs
Average Volume643,731 shs
Market Capitalization$65.82 billion
P/E Ratio60.01
Dividend YieldN/A
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. Read More…

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
Current SymbolNASDAQ:ISRG



Sales & Book Value

Annual Sales$3.72 billion
Cash Flow$11.40 per share
Book Value$67.29 per share


Net Income$1.13 billion


Market Cap$65.82 billion
Next Earnings Date1/23/2020 (Estimated)

Receive ISRG News and Ratings via Email

Sign-up to receive the latest news and ratings for ISRG and its competitors with MarketBeat's FREE daily newsletter.

Intuitive Surgical (NASDAQ:ISRG) Frequently Asked Questions

What is Intuitive Surgical's stock symbol?

Intuitive Surgical trades on the NASDAQ under the ticker symbol "ISRG."

When did Intuitive Surgical's stock split? How did Intuitive Surgical's stock split work?

Shares of Intuitive Surgical split on Friday, October 6th 2017. The 3-1 split was announced on Friday, August 11th 2017. The newly created shares were payable to shareholders after the closing bell on Thursday, October 5th 2017. An investor that had 100 shares of Intuitive Surgical stock prior to the split would have 300 shares after the split.

How were Intuitive Surgical's earnings last quarter?

Intuitive Surgical, Inc. (NASDAQ:ISRG) released its quarterly earnings data on Thursday, October, 17th. The medical equipment provider reported $3.43 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.99 by $0.44. The medical equipment provider had revenue of $1.13 billion for the quarter, compared to the consensus estimate of $1.06 billion. Intuitive Surgical had a return on equity of 18.26% and a net margin of 30.94%. The company's revenue was up 22.5% on a year-over-year basis. During the same period in the previous year, the company earned $2.83 earnings per share. View Intuitive Surgical's Earnings History.

When is Intuitive Surgical's next earnings date?

Intuitive Surgical is scheduled to release their next quarterly earnings announcement on Thursday, January 23rd 2020. View Earnings Estimates for Intuitive Surgical.

What price target have analysts set for ISRG?

14 brokers have issued 1 year price objectives for Intuitive Surgical's stock. Their forecasts range from $375.00 to $633.00. On average, they anticipate Intuitive Surgical's stock price to reach $586.50 in the next year. This suggests a possible upside of 3.0% from the stock's current price. View Analyst Price Targets for Intuitive Surgical.

What is the consensus analysts' recommendation for Intuitive Surgical?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Intuitive Surgical in the last year. There are currently 1 sell rating, 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Intuitive Surgical.

What are Wall Street analysts saying about Intuitive Surgical stock?

Here are some recent quotes from research analysts about Intuitive Surgical stock:
  • 1. According to Zacks Investment Research, "Intuitive Surgical ended the first quarter on a dull note, with earnings and revenues lagging estimates. Contraction in the gross and operating margin is worrisome. Additionally, the da Vinci system is in the early stages of adoption in some of the markets outside the United States which is likely to impede placements. Intense competition in the global MedTech space is concerning as well. However, the flagship da Vinci procedures recorded solid growth in the quarter. In fact, management expects strong procedure growth in 2019. The company looks to accelerate its business in China, following the clearance of da Vinci Xi system. Sales outside the United States surged as well. Management is optimistic about the recent approvals for the Ion endoluminal system, IRIS augmented reality product and the da Vinci SP Surgical System. Meanwhile, the newly-formed Intuitive Foundation is expected to improve patient outcome." (4/24/2019)
  • 2. BTIG Research analysts commented, "like we previewed, ISRG posted a healthy beat on procedures and system units placed but reported a slight miss on sales (increased leases) and opex came in near the top end of guidance, causing EPS to miss. We understand the benefits of offering several routes to system acquisition and the leases do not bother us. Getting more systems out there and surgeons trained before any significant competition makes sense. The continued increased spending is a concern. While we gather robotics is in the early days, the increased spending started a few years ago and what was initially discussed as a one- or two-year plan has become now at least a three- or four-year plan that seems like it may last a long time. With guidance revised to a 24-28% y/y increase vs the initial 20-28%, investors may pause." (4/21/2019)
  • 3. Cantor Fitzgerald analysts commented, ": We reiterate our Overweight rating on shares of ISRG and maintain our PT of $620. ISRG reported 4Q18 results consistent with its preliminary announcement (1/9). ISRG delivered 19% procedure growth for 4Q18, largely driven by US general surgery and worldwide urology. ISRG reiterated its procedure growth guidance (13-17%), however we expect initial guidance to prove conservative as it has over the past several years. Management plans to increase opex by 20-28% in 2019, which comes as a surprise. We expect investors to have an initial negative reaction to the expected significant increase in spending, but we think the investments will fuel future top-line growth and accelerate ISRG’s pipeline." (1/25/2019)
  • 4. Northland Securities analysts commented, "We are tweaking our models accordingly, and are introducing our FY20 numbers. Key Points Instrument & Accessory revs @ $539M vs. our estimate @ $535M. Systems revs @ $340M vs. our estimate @ $327M." (1/10/2019)

Has Intuitive Surgical been receiving favorable news coverage?

News headlines about ISRG stock have been trending very negative recently, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Intuitive Surgical earned a media sentiment score of -3.4 on InfoTrie's scale. They also gave news articles about the medical equipment provider a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the next few days. View News Stories for Intuitive Surgical.

Are investors shorting Intuitive Surgical?

Intuitive Surgical saw a drop in short interest in the month of October. As of October 15th, there was short interest totalling 2,080,000 shares, a drop of 10.0% from the September 15th total of 2,310,000 shares. Based on an average daily volume of 619,500 shares, the short-interest ratio is presently 3.4 days. Approximately 1.8% of the company's shares are sold short. View Intuitive Surgical's Current Options Chain.

Who are some of Intuitive Surgical's key competitors?

What other stocks do shareholders of Intuitive Surgical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Intuitive Surgical investors own include NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), Boeing (BA), Paypal (PYPL), Visa (V), salesforce.com (CRM), Adobe (ADBE), Mastercard (MA) and Micron Technology (MU).

Who are Intuitive Surgical's key executives?

Intuitive Surgical's management team includes the folowing people:
  • Dr. Gary S. Guthart, CEO, Pres & Director (Age 53)
  • Mr. Marshall L. Mohr, Exec. VP & CFO (Age 63)
  • Mr. Salvatore J. Brogna, Exec. VP & COO (Age 64)
  • Mr. David J. Rosa, Exec. VP & Chief Bus. Officer (Age 51)
  • Dr. Myriam J. Curet McAdams, Exec. VP & Chief Medical Officer (Age 62)

Who are Intuitive Surgical's major shareholders?

Intuitive Surgical's stock is owned by many different of institutional and retail investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (0.41%), California Public Employees Retirement System (0.20%), Rhumbline Advisers (0.18%), CIBC Private Wealth Group LLC (0.15%), Stonehage Fleming Financial Services Holdings Ltd (0.15%) and New York State Teachers Retirement System (0.13%). Company insiders that own Intuitive Surgical stock include Amal M Johnson, Craig H Barratt, Curet Myriam, David J Rosa, Gary S Guthart, Jamie Samath, Lonnie M Smith, Mark J Meltzer, Mark J Rubash, Marshall Mohr, Michael A Friedman, Reiter Kara Andersen and Salvatore Brogna. View Institutional Ownership Trends for Intuitive Surgical.

Which institutional investors are selling Intuitive Surgical stock?

ISRG stock was sold by a variety of institutional investors in the last quarter, including CIBC Private Wealth Group LLC, First Trust Advisors LP, SG Americas Securities LLC, State of Tennessee Treasury Department, Picton Mahoney Asset Management, Artemis Investment Management LLP, Gateway Investment Advisers LLC and UMB Bank N A MO. Company insiders that have sold Intuitive Surgical company stock in the last year include Curet Myriam, Gary S Guthart, Jamie Samath, Lonnie M Smith, Marshall Mohr, Michael A Friedman, Reiter Kara Andersen and Salvatore Brogna. View Insider Buying and Selling for Intuitive Surgical.

Which institutional investors are buying Intuitive Surgical stock?

ISRG stock was acquired by a variety of institutional investors in the last quarter, including State of New Jersey Common Pension Fund D, Assenagon Asset Management S.A., California Public Employees Retirement System, Sumitomo Mitsui Trust Holdings Inc., State of Michigan Retirement System, Teacher Retirement System of Texas, Virginia Retirement Systems ET AL and Cadinha & Co. LLC. View Insider Buying and Selling for Intuitive Surgical.

How do I buy shares of Intuitive Surgical?

Shares of ISRG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Intuitive Surgical's stock price today?

One share of ISRG stock can currently be purchased for approximately $569.54.

How big of a company is Intuitive Surgical?

Intuitive Surgical has a market capitalization of $65.82 billion and generates $3.72 billion in revenue each year. The medical equipment provider earns $1.13 billion in net income (profit) each year or $9.49 on an earnings per share basis. Intuitive Surgical employs 5,527 workers across the globe.View Additional Information About Intuitive Surgical.

What is Intuitive Surgical's official website?

The official website for Intuitive Surgical is http://www.intuitive.com/.

How can I contact Intuitive Surgical?

Intuitive Surgical's mailing address is 1020 KIFER ROAD, SUNNYVALE CA, 94086. The medical equipment provider can be reached via phone at 408-523-2100 or via email at [email protected]

MarketBeat Community Rating for Intuitive Surgical (NASDAQ ISRG)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  847 (Vote Outperform)
Underperform Votes:  603 (Vote Underperform)
Total Votes:  1,450
MarketBeat's community ratings are surveys of what our community members think about Intuitive Surgical and other stocks. Vote "Outperform" if you believe ISRG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ISRG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel